At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions

Investing.com -- Eli Lilly (NYSE:LLY) has increased the price of its weight loss drug Mounjaro in the United Kingdom by up to 170%, according to the Financial Times on Thursday. The pharmaceutical company’s price for a month’s supply of the highest doses of Mounjaro will rise from £122 to £330, the FT reported.

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330. The price hike is not directly related to the US MFN order, despite coinciding with international drug pricing discussions. Weight-loss medication in the UK is going to make both people and their wallets lighter.